Pilot Study of Cisplatin, Etoposide, Bleomycin and Escalating Dose Cyclophosphamide Therapy for Children With High Risk Malignant Germ Cell Tumors.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cyclophosphamide (Primary) ; Bleomycin; Cisplatin; Etoposide; Filgrastim
- Indications Choriocarcinoma; Germ cell and embryonal neoplasms; Teratoma; Yolk sac tumour
- Focus Adverse reactions; Therapeutic Use
- 17 Oct 2013 Biomarkers information updated
- 12 Mar 2013 Primary endpoint added as reported by ClinicalTrials.gov.
- 28 Oct 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.